Find clinical trials for Triple Negative Breast Cancer in Durham, NC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Durham, NC, USA:
This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative b ...
Phase 2
Chapel Hill, North Carolina, United States and 9 other locations
This research study is studying Ruxolitinib as possible treatment for Inflammatory Breast Cancer (IBC).The Following drugs will be ...
Phase 2
Durham, North Carolina, United States and 3 other locations
doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...
Phase 3
Cary, North Carolina, United States and 216 other locations
avelumab with sacituzumab govitecan works in treating patients with triple negative breast cancer that is stage I...
Phase 2
Durham, North Carolina, United States and 11 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Durham, North Carolina, United States and 166 other locations
study explores the safety of escalating doses of chimeric antigen receptor T cells (CAR-T) cells in subjects with relapsed/refractory triple-...
Phase 1
Chapel Hill, North Carolina, United States
(pembrolizumab) and chemotherapy for lymph node-positive, triple negative (TN) or hormone receptor positive/HER2-negative ...
Phase 2
Durham, North Carolina, United States and 9 other locations
(ABBV-181) and/or chemotherapy in participants with selected solid tumors. This study consists of 2 main parts, a dose-escalation phase and ...
Phase 1
Durham, North Carolina, United States and 25 other locations
(HCC), pancreatic ductal adenocarcinoma (PDAC), biliary tract cancers (BTC), esophageal squamous cell carcinoma (ESCC), triple negative...
Phase 1
Durham, North Carolina, United States and 52 other locations
in participants with checkpoint inhibitor (CPI) treated and naïve relapsed and refractory (R/R) tumors.The main purpose of the Biomarker Co...
Phase 1, Phase 2
Durham, North Carolina, United States and 7 other locations
Clinical trials
Research sites
Resources
Legal